38
https://pubmed.ncbi.nlm.nih.gov/38116716
In T3 supraglottic cancers treated with IMRT, increasing primary tumor volume is associated with worse overall and disease-free survival.
“Primary Tumor Volume Influences Survival in Supraglottic Cancers Treated with IMRT and T3 Stage”
